We’re inspired by a single vision:

Transforming patients' lives through science

Our Mission

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases

Our Vision

To be the world's leading biopharma company that transforms patients' lives through science

Bristol Myers Squib logo
Evolving our Brand

To reflect the transformation of our company, we have evolved our company brand. We drew inspiration for our brand identity from our patients and our people. Our symbol, the hand, is a simple, universal expression of healing, of giving and receiving care. It is a representation of humanity, of the personal touch we bring to our work and to every treatment we pioneer. Our brand fully embodies our vision, and embraces our commitment of compassionate science and putting patients and people first.

Letter from the Chairman and CEO

Letter from the Chairman and CEO

At Bristol Myers Squibb, we are inspired by our mission – to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Every day, we focus on innovations that drive meaningful breakthroughs so we can bring life-saving medicines to people around the world.

2019 was a transformative year for us.

Giovanni Caforio, M.D.
Chairman of the Board and Chief Executive Officer

Continue Reading
Giovanni Caforio
numbers

* Full Year GAAP: *Includes Celgene product revenues from November 20, 2019, which was the date of the closing of the acquisition, through December 31, 2019. See “Quarterly Package of Financial Information,” available on bms.com/investors. ** Pro Forma Full Year: Reflects product revenues for the period prior to November 20, 2019, which was the date of the Celgene acquisition. All product revenues prior to November 20, 2019 have been recast to exclude foreign currency hedge gains and losses. See “Quarterly Package of Financial Information” available on bms.com/investors.

Transforming Patients’ Lives Through Science

People and Business Resource Groups

Inspired by Patients. Focused on Business. Powered by Our People.

Global Diversity & Inclusion (GD&I) is essential to our values and strategy. We strive to create a Company culture that brings out the best in everyone and advances our mission to discover, develop and deliver innovative medicines to help patients prevail over serious diseases.

The People and Business Resource Groups (PBRGs) are a transformative business model within GD&I that gives us a competitive advantage in a complex biopharmaceutical industry – one that has seen many mergers and acquisitions, shifts in global policy, and changing patient and talent demographics. PBRGs are the voices of our workforce and the trusted line-of-sight into the patient experience. The PBRGs help drive business performance, innovation, and leadership development with more than 11,000 global members while strategically engaging with business, governmental and community partners to build BMS’s reputation and trust with external stakeholders.

Each of the eight PBRGs is managed by an experienced, high potential full-time leader. PBRG Leads have significant industry experience and in-depth business, medical and scientific research backgrounds. They report to a member of the BMS Executive Leadership Team and act as senior advisors to the businesses, with significant responsibilities including development of three-year business plans.

Here are some of the dynamic ways our PBRGs are making a substantive business difference for our patients, our communities and our workforce:

Continue Reading
20-PBRG-Leads-1

At Bristol Myers Squibb, employees like associate researcher Mahwish Khalid are passionate about the work they do to help transform patients’ lives through science.